Evidence map›Paper›PMID 40894116›Full record

ArticleInternational journal of innovative science and research technology2025

Advances in Cellular and Molecular Biology Assays: A Review of Gold Standard Methods.

Katiana Simões Lopes Kittelson, Allana Cristina Faustino Martins, Gizele Celante, Arquimedes Gasparotto, Roberto da Silva Gomes

Abstract read
In one paragraph

Article in International journal of innovative science and research technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Katiana Simões Lopes KittelsonLaboratory of Cardiovascular Pharmacology (LaFaC), Faculty of Health Sciences, Federal University of Grande Dourados (UFGD), Dourados, MS, Brazil.
Allana Cristina Faustino MartinsDepartment of Pharmaceutical Sciences, College of Health and Human Sciences, North Dakota State University (NDSU), Fargo, ND, United States.
Gizele CelanteDepartment of Pharmaceutical Sciences, College of Health and Human Sciences, North Dakota State University (NDSU), Fargo, ND, United States.
Arquimedes GasparottoLaboratory of Cardiovascular Pharmacology (LaFaC), Faculty of Health Sciences, Federal University of Grande Dourados (UFGD), Dourados, MS, Brazil.
Roberto da Silva GomesDepartment of Pharmaceutical Sciences, College of Health and Human Sciences, North Dakota State University (NDSU), Fargo, ND, United States.

Funding

Targeting CLEC-2/podoplanin as a therapeutic strategy for pancreatic cancerP20GM109024 · NIGMS · NORTH DAKOTA STATE UNIVERSITY · PI Sanku Mallik · 2016 to 2026
$20.5M
NIGMS NIH HHS P20 GM109024
6 · The paper itself

Abstract

Considering the number of available methods in molecular and cellular biology and the rapid development of new technologies, the need for an updated guide on what is currently applied and how to choose the best method for a specific goal has increased. Gold standard methods are known for their accuracy and reliable data under certain circumstances, allowing replicability. This perspective aims to characterize and define the current gold standard techniques from the last five years, enlighten their historical background, cite drawbacks and benefits, and delimit possible future aspects.

Indexed as

methodological techniquesMolecular medicinemultiomics

Identifiers

PMID40894116
PMCPMC12393051

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.